Skip to content

Strategy to obtain warfarin or direct oral anticoagulant's benefit by evaluating registry: Strawberry study

Strategy to obtain warfarin or direct oral anticoagulant's benefit by evaluating registry: Strawberry study - Strategy to obtain warfarin or direct oral anticoagulant's benefit by evaluating registry: Strawberry study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000025721
Enrollment
400
Registered
2017-03-01
Start date
2017-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

None listed

Sponsors

Center for Comprehensive Care and Research on Memory Disorders, National Center for Geriatrics and Gerontology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with NVAF who: 1. are taking an oral anticoagulant at the time of enrollment 2. can undergo a brain magnetic resonance imaging (MRI) at the time of enrollment 3. have provided informed consent in writing 4. are between the ages of 40 and 84 years at the time of enrollment 5. have a Clinical Dementia Rating (CDR) global score of 0 to 0.5 and a Mini-Mental State Examination (MMSE) score of 20 to 30 6. and are accompanied by a study partner (someone who knows how the patient lives)

Exclusion criteria

Exclusion criteria: 1. Patients with valvular atrial fibrillation 2. Patients unable to undergo MRI examination, or MRI cannot be evaluated due to body movement, etc. 3. Patients with dementia with a CDR global score greater than or equal to 1 or MMSE less than 20 4. 6 months or less since occurrence of stroke 5. Less than or equal to 6 years of education 6. Judged by an investigator to be ineligible to participate as a study subject

Design outcomes

Primary

MeasureTime frame
Change in MMSE from time of enrollment until 3 years after enrollment

Secondary

MeasureTime frame
1. Change in Montreal Cognitive Assessment (MoCA) from time of enrollment until 3 years after enrollment 2. Time until occurrence of any death, stroke, or cardiovascular event 3. Change in CDR global score from time of enrollment until 3 years after enrollment 4. Change in Clinical Dementia Rating Sum of Boxes (CDR-SB) score from time of enrollment Time until hemorrhagic or ischemic event

Countries

Japan

Contacts

Public ContactNaoki Saji

Center for Comprehensive Care and Research on Memory Disorders, National Center for Geriatrics and G Strawberry Registry Secretariat

strawberry@ncgg.go.jp0562-46-2311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026